Dr. Ankur Bahl

Overview & ExpertiseDr. Ankur Bahl is a medical oncologist and hemato-oncology specialist practicing in North India. Serving as Senior Director of Medical Oncology at Fortis Memorial Research Institute, Gurugram, he possesses over two decades of clinical and clinical trial experience. His core clinical focus includes administering precision immunotherapy, targeted molecular therapies, hormonal agents, and tailored chemotherapy protocols for lung cancer, head and neck malignancies, breast cancer, GI tumors, acute leukemias, and lymphomas.Education & Academic CredentialsDr. Bahl completed his MBBS (2003) and MD in Internal Medicine (2007) at Maulana Azad Medical College (MAMC), Delhi. He pursued his super-specialty DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi (2012). Additionally, he completed advanced international training in drug interactions, adverse drug reactions, and pharmacovigilance at the University of Oxford, UK.Research Leadership & Academic ForumsDr. Bahl is celebrated for authoring India's largest real-world research dataset on Cetuximab targeted therapy in head and neck cancer patients. He previously served as Director of Medical Oncology at Max Super Speciality Hospital, Saket, and Senior Consultant at Rajiv Gandhi Cancer Institute. He is the founder of several international oncology educational networks, including Live Oncology Tumor Boards and Evidence-Based Debates in Oncology.